Eyeworld

NOV 2017

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/892879

Contents of this Issue

Navigation

Page 74 of 118

EW GLAUCOMA 72 November 2017 has evolved over time. It has distinct advantages over transscleral cyclo- photocoagulation in offering direct visualization of the surgical process to ensure intraoperatively that the surgical objective is met and mini- mizing damage to the surrounding ocular tissues. It offers a viable option in IOP reduction by reducing aqueous production, and represents the other end of the spectrum in glaucoma therapy that focuses large- ly on enhancing aqueous outflow. "I perform this surgery often in my practice, usually in combina- tion with angle closure patients and some with refractory glaucoma," Dr. Izquierdo Villavicencio said. "I rec- ommend ECP for surgeons who are experienced with glaucoma surgery, as there is a learning curve." EW References 1. Berke S. Data Supports Safety and Efficacy of Phaco/ECP. Review of Ophthalmology. June 13, 2006. 2. Kahook M, et al. Endoscopic Cyclophotoco- agulation: Advice on improving your technique and therapeutic outcomes. Glaucoma Today. November/December 2006:24–29. Editors' note: Dr. Izquierdo Villavicen- cio has no financial interests related to his comments. Contact information Izquierdo Villavicencio: juancarlosizq@gmail.com 60%. The study reported significant- ly lower IOP in phaco/ECP eyes and significantly fewer medications com- pared to eyes that had phaco alone. The investigators concluded that their statistical results were powerful enough to suggest a paradigm shift in the treatment of cataract patients with concurrent glaucoma; com- bining ECP with phaco should be considered for medically controlled glaucoma patients with cataract. 1 Another study demonstrated ECP as a safe and effective method for treating various types of glauco- ma, including patients taking multi- ple medications and those in whom maximal medical therapy has failed. The investigators achieved 30–40% pressure reductions after 360-degree treatments in more than 300 cases with primary and secondary open angle glaucomas, neovascular glau- coma, chronic angle closure, and phakic glaucoma, along with at least 60% reductions in patients' use of topical medication. 2 ECP is carried out after cataract surgery. A probe is introduced into the eye through the clear cornea incision with a camera and fiber op- tic cables that allow the surgeon to view the surgery on a monitor. Max- imum effects are achieved through the treatment of 270–360 degrees around the eye. ECP is a technology that has been used over several decades and A F R E S H P E R S P E C T I V E ™ 2500 Sandersville Rd ■ Lexington KY 40511 USA lacrivera.com ( 855 ) 857-0518 © 2017 Lacrivera, a division of Stephens Instruments. All rights reserved. Refresh your dry eye practice. Use promo code FLEXEW for introductory pricing Introducing the new VeraPlug™ FlexFit,™ a familiar design with the same simple sizing, patient comfort, and retention that you expect. Lacrivera offers a fresh approach to bring greater value to your dry eye practice. Endocyclophotocoagulation continued from page 70 " I perform this surgery often in my practice, usually in combination with angle closure patients and some with refractory glaucoma. I recommend ECP for surgeons who are experienced with glaucoma surgery, as there is a learning curve. " —Juan Carlos Izquierdo Villavicencio, MD

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - NOV 2017